Stay updated on Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 to the page; removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.2%
    Check dated 2025-12-23T08:37:39.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Minor system revision updating from v3.3.1 to v3.3.2, with no visible changes to study content, eligibility, or contact details.
    Difference
    0.2%
    Check dated 2025-12-01T16:55:21.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1; the page now displays the new revision label and removes the previous one.
    Difference
    0.1%
    Check dated 2025-11-24T14:34:12.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The banner about the lapse in government funding and NIH operating status was removed.
    Difference
    0.4%
    Check dated 2025-11-17T06:54:43.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Core study details, eligibility criteria, and endpoints appear unchanged; only minor visual/layout adjustments were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-10T04:55:43.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    The update shows minor UI/formatting adjustments and section reorganization without changes to the study's key details.
    Difference
    0.4%
    Check dated 2025-11-03T01:18:32.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.